Katy Rezvani/LinkedIn
Jun 27, 2025, 06:40
Katy Rezvani Gave One of the 2025 Susan Swerling Lecture on NK Cell Therapy at Dana-Farber Cancer Institute
Katy Rezvani, Vice President and Head of Institute for Cell Therapy Discovery and Innovation at MD Anderson Cancer Center, shared a post on LinkedIn:
“On Tuesday, I had the privilege of giving one of the 2025 Susan Swerling Lectures at The Dana-Farber Cancer Institute, Harvard Medical School, as part of this year’s series on Engineering of Therapeutic Immune Cells.
It was a pleasure to share our work on NK cell therapy from MD Anderson, and to reflect on the clinical and scientific progress made possible through the efforts of so many exceptional colleagues, collaborators, and patients.
I’m especially grateful to the organizers for the kind invitation, and to the Dana-Farber community for such a warm and thoughtful welcome.”
More posts featuring Katy Rezvani on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 13:14
Aug 8, 2025, 13:14
Aug 8, 2025, 13:11